Bioassay of dixathion for possible carcinogenicity.

Format Electronic
Publication InfoBethesda, Md. : U. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1978.
Description1 online resource (101 unnumbered pages) : illustrations.
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo29671
Subjects

Other author/creatorHazleton Laboratories America.
Other author/creatorNational Institutes of Health (U.S.)
Other author/creatorCarcinogenesis Testing Program (U.S.)
Other author/creatorNational Cancer Institute (U.S.). Division of Cancer Cause and Prevention.
SeriesNational Cancer Institute carcinogenesis technical report series ; no. 125
National Cancer Institute carcinogenesis technical report series ; no. 125. ^A1107162
DHEW publication no. (NIH) 78-1380. ^A204
General noteTitle from title screen (viewed on Oct. 11, 2012).
General note"CAS no. 78-34-2."
General note"NCI-CG-TR-125."
General noteDHEW publication ; no. (NIH) 78-1380.
General noteConducted for the Carcinogenesis Testing Program, National Cancer Institute, by Hazleton Laboratories America, inc., Vienna, Va.
Issued in other formPrint version: Hazleton Laboratories America. Bioassay of dixathion for possible carcinogenicity
Technical rpt numberNCI-CG-TR-125
GPO item number0507-G-12 (online)
Govt. docs number HE 20.3159/2:125